Research & Development: Page 76
-
PharmaVoice Team/PharmaVoice
Annual DIA Preview Showcase
SPECIAL FEATURE DIA 45TH ANNUAL MEETING We all share in the responsibility to work together to strengthen the science used in pharmaceutical product development, evaluation, and review,” says Program Chair Nancy Smith, Ph.D., former director of the Office of Training and Communications, CDER, at ...
By PharmaVoice Team • May 25, 2009 -
PharmaVoice Team/PharmaVoice
Meet the Chief Scientific Officers
The CSO Role The chief scientist officer helps set a company’s strategy, interacts with investors and board of directors, and helps people understand the science behind new products. MCKERNAN. PFIZER. A CSO at Pfizer handles everything from the idea to proof of concept, establishing and building ...
By Denise Myshko • May 23, 2009 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Upfront
UPFRONT Milestones 20TH ANNIVERSARY John R. Vogel Associates Inc. celebrates 20 years of assisting pharmaceutical and biopharmaceutical companies and the pharmaceutical service providers to enhance results achieved through outsourcing and strategic alliances. Mr. Vogel, who founded the company in...
By PharmaVoice Team • May 23, 2009 -
PharmaVoice Team/PharmaVoice
Defining a Career Path in the New Pharmaceutical Era
Avoiding the Bull’s-Eye When management needs to trim the workforce, there are ways to avoid being the target. The value of an employee increases if he or she has a can-do attitude, is a problem solver, and can react quickly to changes and challenges in the business environment. Binner. AstraZene...
By Robin Robinson • April 27, 2009 -
PharmaVoice Team/PharmaVoice
Creating Value through Personalized Medicine
BY DENISE MYSHKO The use of pharmacogenomics to develop personalized medicine will lead to a culture change for the pharmaceutical industry. While initially disruptive, personalized medicine will lead to longer-term success for pharmaceutical companies. Dr. Gary Kurtzman Safeguard Scientifics The...
By Denise Myshko • April 27, 2009 -
PharmaVoice Team/PharmaVoice
Una Ryan, Ph.D.: Clear Intent
BY KIM RIBBINK Dr. Una Ryan has made significant inroads in the biotechnology world. Not only has she helped to successfully navigate a company through major change, she has also played a key role in improving business conditions for other biotech companies. Now she is applying her forward-thinki...
By Kim Ribbink • April 23, 2009 -
PharmaVoice Team/PharmaVoice
Last Word
The industry is outsourcing the activities that are going to be core to being prosperous in the future, while hanging on to activities that will provide less and less value. Disruption equals Opportunity Please explain the concept of disruptive innovation and the opportunities this poses for the ...
By PharmaVoice Team • April 23, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Andy AJELLO Novo Nordisk Appoints Diabetes Sales VP Novo Nordisk, a global healthcare company focusing on diabetes care, has promoted Andy Ajello to VP for national diabetes sales, managed care, and government accounts. Previously, Mr. Ajello was associate VP of diabetes sales...
By PharmaVoice Team • April 23, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Model N Application Provides Strategic Insights to Life-Sciences Firms New Momentum Offers AntiCounterfeiting Software Novartis Launches Meningitis Website Website Highlights Pink Tank’s Expertise in Women’s Healt...
By PharmaVoice Team • April 23, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Electronic Delivery of CME Gains Popularity Sidebar: Average % of CME Delivered Via Internet Smaller, Refocused Salesforces Could Create Greater Value for Patients Sidebar: Pharma Job Cuts Announced as of October 2008 Ef...
By PharmaVoice Team • April 23, 2009 -
PharmaVoice Team/PharmaVoice
UpFront
Milestones 10th anniversary marked with rebranding GxP Consulting (formerly GxPi Ltd.), a provider of compliance services to the pharma and biopharma industries, has launched its newly designed and improved Website and a new name as it celebrates 10 years in business. The new Website, accessible ...
By PharmaVoice Team • April 23, 2009 -
PharmaVoice Team/PharmaVoice
Differentiating KOLs and Advocates: The Importance of a Targeted Strategy
The terms key opinion leader (KOL) and advocate are often used interchange ably; but, they define t w o very different target groups. A strategy to clearly identify and characterize KOLs, to then con vert them to and deploy them as advocates, and finally to build and maintain a lasting relationsh...
By PharmaVoice Team • April 14, 2009 -
PharmaVoice Team/PharmaVoice
Physician Learning: Improving the Process
This program will profoundly improve my practice of medicine. It was exactly what I was looking for,” a primarycare physi cian recently stated as he was leaving a continuing medical education (CME) pro gram on hypertension. This is a high compliment indeed and a goal that all CME providers strive...
By PharmaVoice Team • April 14, 2009 -
PharmaVoice Team/PharmaVoice
Delivering CME to Physicians: A Look at the Future
Continuing medical education has always sought to provide physicians with accurate, targeted learning opportuni ties. But delivering that critical infor mation is becoming more difficult. Many commercial supporters have already changed how they support CME because of the OIG, PhRMA guidelines, co...
By PharmaVoice Team • April 14, 2009 -
PharmaVoice Team/PharmaVoice
Mission Possible: Transform the Clinical-Trial Process
The mission of the Clinical Trials Transformation Initiative (CTTI) is to identify practices that will increase the quality and efficiency of clinical trials. According to the organization, its first year was defined by great stakeholder enthusiasm, a strong organizational foundation, and rapid p...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Dr. George Scangos: Gene Excellence
BY KIM RIBBINK With a practical approach to research and discovery, Dr. George Scangos has led Exelixis from a genomic research firm to a drug discovery and development company with expertise in oncology and metabolism. Research, by necessity, can often be an esoteric pursuit. But for George Scan...
By Kim Ribbink • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 34 PharmaOutlet Kit Howard looks at what makes professional certification valuable. 36 PharmaTrax Sales, marketing, and R&D trends from industry analysts 38 What’s New New healthcare-related produc...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Last Word
Novartis Oncology’s David Epstein discusses the growing relevance of diagnostics in drug development. Mr. Epstein credits breakthroughs in biology and bioinformatics with an increased understanding of the genome that will enable developers to do a better job of matching the right drug with the ri...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Knexus Provides Business-to-Business Social Media Platform Knexus Tech has introduced a business-to-business (B2B) social media platform that gives companies a quick, easy way to engage busy business professionals with quality ins...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry Verified Physicians Ensure Quality Data As online physician panels gain popularity among pharmaceutical and medical device companies that conduct Web-based surveys, research shows there is little interest in verifying that the...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Kit Howard, M.S., CCDM, CRCP What makes professional certification valuable? In recent years, there has been a proliferation of certification programs within the pharma/biotech/devices world. Some are broad-based, such as project management (e.g., the Project Management Institute’s...
By Kit Howard • March 25, 2009 -
PharmaVoice Team/PharmaVoice
UpFront
Investment Portfolio R&D Spending by U.S. Biopharmaceutical Companies Increases 3% in 2008 A new report reveals that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3% from 2007, according to a combined analysis conducted by Burr...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Advair: The Drug to Watch
The inhaler is well on its way to blockbuster status in the U.S., where it debuted in April 2001. Advair Diskus already is the fastestgrowing asthma medicine in Europe, where it is marketed under the name Seretide, and Goldman Sachs analysts fore cast that global sales of the drug will reach $2.4...
By Lynda Sears • March 17, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ePocrates To Collaborate With Express Scripts on HANDHELD FORMULARY INITIATIVE ePocrates has agreed to incorporate the formu lary information of Express Scripts Inc., a national pharmacy benefits manager, into the ePocrates Rx Form...
By PharmaVoice Team • March 11, 2009 -
PharmaVoice Team/PharmaVoice
What's New
Ventiv Health Inc., MDS Pharma Services,and Paul Capital Partners have joined forces to provide lifesci ences companies with a broad range of development, commercialization,and investment support. The alliance combines the drug discovery and development expertise of MDS Pharma Services,the commer...
By PharmaVoice Team • March 11, 2009
Previous
